LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Breathing. That critical inhale/exhale operation of the lungs is something we often take for granted — until something goes wrong and respiratory problems result. The Center for Acute Respiratory ...
Please provide your email address to receive an email when new articles are posted on . Odds for survival on ECMO to transplant went down if the patient had an older age at listing. Survival did not ...
Please provide your email address to receive an email when new articles are posted on . Among patients receiving extracorporeal membrane oxygenation, the presence of obesity did not impact mortality ...
San Antonio, Texas – June 3, 2024 – Recognizing an unusual prevalence of bloodstream infections (BSI) that threatened extremely ill patients receiving Extracorporeal Membrane Oxygenation, or ECMO, ...
A 40-year-old patient suffering from swine flu got a new lease of life after undergoing the extra corporeal membrane oxygenation (ECMO) procedure at a private hospital in the city. A patient is ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days' use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback